Report Detail
Global (United States, European Union and China) Sulphonamides Market Research Report 2019-2025
- RnM3403920 |
- 09 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
In 2019, the market size of Sulphonamides is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sulphonamides.
This report studies the global market size of Sulphonamides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sulphonamides production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Market Segment by Product Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Market Segment by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Sulphonamides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sulphonamides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Sulphonamides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Sulphonamides Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Orally Absorbable Sulfonamide
- 1.3.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
- 1.3.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
- 1.4 Market Segment by Application
- 1.4.1 Global Sulphonamides Market Share by Application (2019-2025)
- 1.4.2 Skin Infections
- 1.4.3 Gastro Intestinal Tract (GIT) Infection
- 1.4.4 Meningitis
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Sulphonamides Production Value 2014-2025
- 2.1.2 Global Sulphonamides Production 2014-2025
- 2.1.3 Global Sulphonamides Capacity 2014-2025
- 2.1.4 Global Sulphonamides Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Sulphonamides Market Size CAGR of Key Regions
- 2.2.2 Global Sulphonamides Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Sulphonamides Capacity by Manufacturers
- 3.1.2 Global Sulphonamides Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Sulphonamides Revenue by Manufacturers (2014-2019)
- 3.2.2 Sulphonamides Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Sulphonamides Market Concentration Ratio (CR5 and HHI)
- 3.3 Sulphonamides Price by Manufacturers
- 3.4 Key Manufacturers Sulphonamides Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Sulphonamides Market
- 3.6 Key Manufacturers Sulphonamides Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Orally Absorbable Sulfonamide Production and Production Value (2014-2019)
- 4.1.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Production and Production Value (2014-2019)
- 4.1.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Production and Production Value (2014-2019)
- 4.2 Global Sulphonamides Production Market Share by Type
- 4.3 Global Sulphonamides Production Value Market Share by Type
- 4.4 Sulphonamides Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Sulphonamides Consumption by Application
6 Production by Regions
- 6.1 Global Sulphonamides Production (History Data) by Regions 2014-2019
- 6.2 Global Sulphonamides Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Sulphonamides Production Growth Rate 2014-2019
- 6.3.2 United States Sulphonamides Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Sulphonamides Import & Export
- 6.4 European Union
- 6.4.1 European Union Sulphonamides Production Growth Rate 2014-2019
- 6.4.2 European Union Sulphonamides Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Sulphonamides Import & Export
- 6.5 China
- 6.5.1 China Sulphonamides Production Growth Rate 2014-2019
- 6.5.2 China Sulphonamides Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Sulphonamides Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Sulphonamides Consumption by Regions
- 7.1 Global Sulphonamides Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Sulphonamides Consumption by Type
- 7.2.2 United States Sulphonamides Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Sulphonamides Consumption by Type
- 7.3.2 European Union Sulphonamides Consumption by Application
- 7.4 China
- 7.4.1 China Sulphonamides Consumption by Type
- 7.4.2 China Sulphonamides Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Sulphonamides Consumption by Type
- 7.5.2 Rest of World Sulphonamides Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Sulphonamides
- 8.1.4 Sulphonamides Product Introduction
- 8.1.5 Abbott Laboratories Recent Development
- 8.2 Boehringer Ingelheim Pharmaceuticals
- 8.2.1 Boehringer Ingelheim Pharmaceuticals Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Sulphonamides
- 8.2.4 Sulphonamides Product Introduction
- 8.2.5 Boehringer Ingelheim Pharmaceuticals Recent Development
- 8.3 Bayer AG
- 8.3.1 Bayer AG Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Sulphonamides
- 8.3.4 Sulphonamides Product Introduction
- 8.3.5 Bayer AG Recent Development
- 8.4 GlaxoSmithKline
- 8.4.1 GlaxoSmithKline Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Sulphonamides
- 8.4.4 Sulphonamides Product Introduction
- 8.4.5 GlaxoSmithKline Recent Development
- 8.5 King Pharmaceuticals
- 8.5.1 King Pharmaceuticals Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Sulphonamides
- 8.5.4 Sulphonamides Product Introduction
- 8.5.5 King Pharmaceuticals Recent Development
- 8.6 Mylan Pharmaceuticals
- 8.6.1 Mylan Pharmaceuticals Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Sulphonamides
- 8.6.4 Sulphonamides Product Introduction
- 8.6.5 Mylan Pharmaceuticals Recent Development
- 8.7 Novartis International AG
- 8.7.1 Novartis International AG Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Sulphonamides
- 8.7.4 Sulphonamides Product Introduction
- 8.7.5 Novartis International AG Recent Development
- 8.8 Pfizer
- 8.8.1 Pfizer Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Sulphonamides
- 8.8.4 Sulphonamides Product Introduction
- 8.8.5 Pfizer Recent Development
- 8.9 Par Pharmaceutical
- 8.9.1 Par Pharmaceutical Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Sulphonamides
- 8.9.4 Sulphonamides Product Introduction
- 8.9.5 Par Pharmaceutical Recent Development
- 8.10 Roche Holding AG
- 8.10.1 Roche Holding AG Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Sulphonamides
- 8.10.4 Sulphonamides Product Introduction
- 8.10.5 Roche Holding AG Recent Development
- 8.11 Sanofi Aventis
- 8.12 Stiefel Laboratories
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Sulphonamides Capacity, Production Forecast 2019-2025
- 9.1.2 Global Sulphonamides Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Sulphonamides Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Sulphonamides Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Sulphonamides Production Forecast by Type
- 9.7.2 Global Sulphonamides Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Sulphonamides Sales Channels
- 10.2.2 Sulphonamides Distributors
- 10.3 Sulphonamides Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Sulphonamides. Industry analysis & Market Report on Sulphonamides is a syndicated market report, published as Global (United States, European Union and China) Sulphonamides Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Sulphonamides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
